Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 1/2003

01-01-2003 | Original Article

Interferon-γ secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type

Authors: Stefania Zanussi, Emanuela Vaccher, Cristina Caffau, Chiara Pratesi, Cinzia Crepaldi, Maria Bortolin, Rosamaria Tedeschi, Doriano Politi, Luigi Barzan, Umberto Tirelli, Paolo De Paoli

Published in: Cancer Immunology, Immunotherapy | Issue 1/2003

Login to get access
Metadata
Title
Interferon-γ secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type
Authors
Stefania Zanussi
Emanuela Vaccher
Cristina Caffau
Chiara Pratesi
Cinzia Crepaldi
Maria Bortolin
Rosamaria Tedeschi
Doriano Politi
Luigi Barzan
Umberto Tirelli
Paolo De Paoli
Publication date
01-01-2003
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 1/2003
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-002-0333-z

Other articles of this Issue 1/2003

Cancer Immunology, Immunotherapy 1/2003 Go to the issue

Original Article

Clinical response after intradermal immature dendritic cell vaccination in metastatic melanoma is associated with immune response to particulate antigen

Acknowledgement to Reviewers

Reviewers 2002

Original Article

Intra-arterial administration of TNF-α followed by arterial ablation is an effective therapy for a regionally confined TNF-resistant rat mammary adenocarcinoma

Original Article

Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia

Original Article

Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line

Original Article

A series of immune responses leading to the induction ofT cell IL-12/IL-18 responsiveness in patientswith relatively large tumor burdens
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits